Fair value (multi-method)
Four independent methods triangulate what TMO is worth. The headline is the Forward-DCF intrinsic value at a normalized growth rate; the margin of safety compares it to the current price.
Estimated fair value (Forward DCF)
$282.05
Method range
$118.08 – $738.19
median $455.66
Valuation methods
Each method’s implied fair value per share and its upside versus the current price. Missing methods (no analyst coverage, negative earnings, etc.) are shown as “—”.
| Method | Fair value | Upside vs price |
|---|---|---|
| Forward DCF | $282.05 | -40.35% |
| Exit multiple | $738.19 | +56.13% |
| Analyst target | $629.27 | +33.09% |
| Graham number | $118.08 | -75.03% |
- Forward DCF$282.05
- Exit multiple$738.19
- Analyst target$629.27
- Graham number$118.08
Stock price
$472.80
FCF / share (TTM)
$2.19
3Y FCF CAGR
-1.4%
Fair value @ hist. growth
$26.10
This analysis is for informational purposes only and is not financial advice. Scenario prices and DCF-style figures depend on your assumptions and data from public filings and estimates. They are not forecasts of future returns.
Implied FCF growth
38.0%
per year over your projection horizon
Margin of safety -1711.8% vs hist-growth DCF
Historical 3Y CAGR
-1.4%
Your model implies
38.0%
Analyst consensus is EPS-only — no comparable FCF / share estimate to show on this basis.
Model inputs
Move sliders to test how the reverse DCF reacts. Historical-growth markers show where the company has actually grown over the last cycle.
Undiscounted FCF per share over 10 years at -1% annual growth.
Sensitivity — implied growth vs your assumptions
Each cell shows the per-share growth rate the market would need to justify the current price at that combination of discount rate (rows) and terminal growth (columns). Your selected inputs are highlighted.
| Row axis: discount rate. Column axis: terminal growth.Terminal g →↓ Discount | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 6.9% | 33.6% | 32.5% | 31.2% | 29.7% | 28.1% |
| 7.9% | 36.8% | 35.8% | 34.8% | 33.6% | 32.3% |
| 8.9% | 39.7% | 38.9% | 38.0% | 37.0% | 35.9% |
| 9.9% | 42.5% | 41.7% | 40.9% | 40.0% | 39.1% |
| 10.9% | 45.1% | 44.4% | 43.7% | 42.9% | 42.1% |
Historical multiples
Each bar is the trailing five-year range (low left, high right). Filled portion runs from low to today; the dot marks today; the small tick marks the five-year median. Low, median, and high are listed under each bar.
Net debt
$31.0B
Total debt − cash
Beta
0.87
Vs market benchmark
Frequently asked questions
Thermo Fisher Scientific (TMO) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation